Annual Non Current Assets
$33.73 M
-$11.78 M-25.89%
31 December 2023
Summary:
Heron Therapeutics annual long term assets is currently $33.73 million, with the most recent change of -$11.78 million (-25.89%) on 31 December 2023. During the last 3 years, it has fallen by -$5.63 million (-14.30%). HRTX annual non current assets is now -34.22% below its all-time high of $51.28 million, reached on 31 December 2021.HRTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$25.59 M
-$1.38 M-5.11%
30 September 2024
Summary:
Heron Therapeutics quarterly long term assets is currently $25.59 million, with the most recent change of -$1.38 million (-5.11%) on 30 September 2024. Over the past year, it has dropped by -$9.63 million (-27.34%). HRTX quarterly non current assets is now -50.10% below its all-time high of $51.28 million, reached on 31 December 2021.HRTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.9% | -27.3% |
| 3 y3 years | -14.3% | -31.5% |
| 5 y5 years | +125.9% | -11.2% |
HRTX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -34.2% | at low | -50.1% | at low |
| 5 y | 5 years | -34.2% | +125.9% | -50.1% | at low |
| alltime | all time | -34.2% | +8127.3% | -50.1% | +8693.8% |
Heron Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.59 M(-5.1%) |
| June 2024 | - | $26.97 M(-15.7%) |
| Mar 2024 | - | $31.98 M(-5.2%) |
| Dec 2023 | $188.77 M(-8.1%) | $33.73 M(-4.2%) |
| Sept 2023 | - | $35.22 M(-2.0%) |
| June 2023 | - | $35.94 M(-15.9%) |
| Mar 2023 | - | $42.72 M(-6.1%) |
| Dec 2022 | $205.44 M(-19.3%) | $45.52 M(-5.5%) |
| Sept 2022 | - | $48.15 M(-3.2%) |
| June 2022 | - | $49.76 M(-2.7%) |
| Mar 2022 | - | $51.13 M(-0.3%) |
| Dec 2021 | $254.42 M(-19.0%) | $51.28 M(+37.4%) |
| Sept 2021 | - | $37.34 M(-0.2%) |
| June 2021 | - | $37.42 M(-3.2%) |
| Mar 2021 | - | $38.64 M(-1.8%) |
| Dec 2020 | $314.20 M(-34.4%) | $39.36 M(+0.9%) |
| Sept 2020 | - | $39.03 M(-2.0%) |
| June 2020 | - | $39.83 M(-1.6%) |
| Mar 2020 | - | $40.49 M(+20.1%) |
| Dec 2019 | $479.06 M(+7.1%) | $33.72 M(+17.0%) |
| Sept 2019 | - | $28.82 M(-6.5%) |
| June 2019 | - | $30.83 M(+4.2%) |
| Mar 2019 | - | $29.59 M(+98.2%) |
| Dec 2018 | $447.25 M(+96.1%) | $14.93 M(+37.8%) |
| Sept 2018 | - | $10.83 M(+36.6%) |
| June 2018 | - | $7.93 M(+16.3%) |
| Mar 2018 | - | $6.82 M(+9.2%) |
| Dec 2017 | $228.06 M(+267.0%) | $6.24 M(+11.4%) |
| Sept 2017 | - | $5.61 M(-6.8%) |
| June 2017 | - | $6.02 M(+1.2%) |
| Mar 2017 | - | $5.94 M(+11.3%) |
| Dec 2016 | $62.14 M(-53.9%) | $5.34 M(+10.5%) |
| Sept 2016 | - | $4.83 M(+5.0%) |
| June 2016 | - | $4.60 M(+26.2%) |
| Mar 2016 | - | $3.65 M(+17.8%) |
| Dec 2015 | $134.75 M(+82.8%) | $3.09 M(-2.0%) |
| Sept 2015 | - | $3.16 M(+4.0%) |
| June 2015 | - | $3.04 M(-2.9%) |
| Mar 2015 | - | $3.13 M(+6.0%) |
| Dec 2014 | $73.73 M(+1.1%) | $2.95 M(-3.0%) |
| Sept 2014 | - | $3.04 M(-2.2%) |
| June 2014 | - | $3.11 M(+1.7%) |
| Mar 2014 | - | $3.06 M(+1.5%) |
| Dec 2013 | $72.92 M(+34.8%) | $3.01 M(+0.1%) |
| Sept 2013 | - | $3.01 M(+4.5%) |
| June 2013 | - | $2.88 M(+1.8%) |
| Mar 2013 | - | $2.83 M(+50.4%) |
| Dec 2012 | $54.09 M(+196.5%) | $1.88 M(+38.6%) |
| Sept 2012 | - | $1.36 M(+10.2%) |
| June 2012 | - | $1.23 M(-1.0%) |
| Mar 2012 | - | $1.24 M(+3.2%) |
| Dec 2011 | $18.24 M(+629.3%) | $1.21 M(+153.2%) |
| Sept 2011 | - | $476.00 K(+63.6%) |
| June 2011 | - | $291.00 K(-19.6%) |
| Mar 2011 | - | $362.00 K(-11.7%) |
| Dec 2010 | $2.50 M(-69.9%) | $410.00 K(-10.9%) |
| Sept 2010 | - | $460.00 K(+1.8%) |
| June 2010 | - | $452.00 K(-22.5%) |
| Mar 2010 | - | $583.00 K(-8.6%) |
| Dec 2009 | $8.31 M(-23.1%) | $638.00 K(-11.9%) |
| Sept 2009 | - | $724.00 K(-10.8%) |
| June 2009 | - | $812.00 K(-8.9%) |
| Mar 2009 | - | $891.00 K(-9.5%) |
| Dec 2008 | $10.82 M(-69.8%) | $984.00 K(-15.4%) |
| Sept 2008 | - | $1.16 M(-8.1%) |
| June 2008 | - | $1.27 M(-1.6%) |
| Mar 2008 | - | $1.29 M(+11.5%) |
| Dec 2007 | $35.80 M(+120.9%) | $1.15 M(+32.8%) |
| Sept 2007 | - | $869.00 K(-0.7%) |
| June 2007 | - | $875.00 K(-8.2%) |
| Mar 2007 | - | $953.00 K(-8.8%) |
| Dec 2006 | $16.21 M | $1.04 M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $1.06 M(-7.4%) |
| June 2006 | - | $1.14 M(-7.5%) |
| Mar 2006 | - | $1.23 M(-6.6%) |
| Dec 2005 | $7.65 M(-50.6%) | $1.32 M(-5.2%) |
| Sept 2005 | - | $1.39 M(+7.8%) |
| June 2005 | - | $1.29 M(-6.1%) |
| Mar 2005 | - | $1.38 M(-9.4%) |
| Dec 2004 | $15.50 M(+37.6%) | $1.52 M(-4.8%) |
| Sept 2004 | - | $1.59 M(-3.3%) |
| June 2004 | - | $1.65 M(+0.7%) |
| Mar 2004 | - | $1.64 M(-13.8%) |
| Dec 2003 | $11.26 M(-29.5%) | $1.90 M(-1.5%) |
| Sept 2003 | - | $1.93 M(-2.8%) |
| June 2003 | - | $1.98 M(-1.3%) |
| Mar 2003 | - | $2.01 M(+10.6%) |
| Dec 2002 | $15.97 M(-26.2%) | $1.81 M(-6.1%) |
| Sept 2002 | - | $1.93 M(-2.6%) |
| June 2002 | - | $1.99 M(+11.6%) |
| Mar 2002 | - | $1.78 M(-5.5%) |
| Dec 2001 | $21.62 M(-13.7%) | $1.88 M(+3.2%) |
| Sept 2001 | - | $1.83 M(-2.8%) |
| June 2001 | - | $1.88 M(-0.2%) |
| Mar 2001 | - | $1.88 M(-3.3%) |
| Dec 2000 | $25.05 M(+47.7%) | $1.95 M(-4.2%) |
| Sept 2000 | - | $2.03 M(-3.7%) |
| June 2000 | - | $2.11 M(-77.5%) |
| Mar 2000 | - | $9.37 M(+301.6%) |
| Dec 1999 | $16.96 M(+32.5%) | $2.33 M(-77.1%) |
| Sept 1999 | - | $10.20 M(+1.0%) |
| June 1999 | - | $10.10 M(+1.0%) |
| Mar 1999 | - | $10.00 M(-2.9%) |
| Dec 1998 | $12.80 M(-15.8%) | $10.30 M(0.0%) |
| Sept 1998 | - | $10.30 M(+1.0%) |
| June 1998 | - | $10.20 M(+4.1%) |
| Mar 1998 | - | $9.80 M(+8.9%) |
| Dec 1997 | $15.20 M(+29.9%) | $9.00 M(+18.4%) |
| Sept 1997 | - | $7.60 M(+5.6%) |
| June 1997 | - | $7.20 M(+7.5%) |
| Mar 1997 | - | $6.70 M(0.0%) |
| Dec 1996 | $11.70 M(-29.1%) | $6.70 M(-5.6%) |
| Sept 1996 | - | $7.10 M(-1.4%) |
| June 1996 | - | $7.20 M(-2.7%) |
| Mar 1996 | - | $7.40 M(+12.1%) |
| Dec 1995 | $16.50 M(+0.6%) | $6.60 M(-5.7%) |
| Sept 1995 | - | $7.00 M(+4.5%) |
| June 1995 | - | $6.70 M(-4.3%) |
| Mar 1995 | - | $7.00 M(-1.4%) |
| Dec 1994 | $16.40 M(+8.6%) | $7.10 M(-22.8%) |
| Sept 1994 | - | $9.20 M(-2.1%) |
| June 1994 | - | $9.40 M(-1.1%) |
| Mar 1994 | - | $9.50 M(+2.2%) |
| Dec 1993 | $15.10 M(-20.9%) | $9.30 M(-2.1%) |
| Sept 1993 | - | $9.50 M(0.0%) |
| June 1993 | - | $9.50 M(+3.3%) |
| Mar 1993 | - | $9.20 M(0.0%) |
| Dec 1992 | $19.10 M(+306.4%) | $9.20 M(+8.2%) |
| Sept 1992 | - | $8.50 M(+7.6%) |
| June 1992 | - | $7.90 M(+5.3%) |
| Mar 1992 | - | $7.50 M(+53.1%) |
| Dec 1991 | $4.70 M(-24.2%) | $4.90 M(0.0%) |
| Sept 1991 | - | $4.90 M(-3.9%) |
| June 1991 | - | $5.10 M(-1.9%) |
| Mar 1991 | - | $5.20 M(-3.7%) |
| Dec 1990 | $6.20 M(-29.5%) | $5.40 M(+31.7%) |
| Sept 1990 | - | $4.10 M(-2.4%) |
| June 1990 | - | $4.20 M(-2.3%) |
| Mar 1990 | - | $4.30 M(-2.3%) |
| Dec 1989 | $8.80 M(-28.5%) | $4.40 M(-2.2%) |
| Sept 1989 | - | $4.50 M(+2.3%) |
| June 1989 | - | $4.40 M(-2.2%) |
| Dec 1988 | $12.30 M(-25.5%) | $4.50 M(0.0%) |
| Dec 1987 | $16.50 M | $4.50 M |
FAQ
- What is Heron Therapeutics annual long term assets?
- What is the all time high annual non current assets for Heron Therapeutics?
- What is Heron Therapeutics annual non current assets year-on-year change?
- What is Heron Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Heron Therapeutics?
- What is Heron Therapeutics quarterly non current assets year-on-year change?
What is Heron Therapeutics annual long term assets?
The current annual non current assets of HRTX is $33.73 M
What is the all time high annual non current assets for Heron Therapeutics?
Heron Therapeutics all-time high annual long term assets is $51.28 M
What is Heron Therapeutics annual non current assets year-on-year change?
Over the past year, HRTX annual long term assets has changed by -$11.78 M (-25.89%)
What is Heron Therapeutics quarterly long term assets?
The current quarterly non current assets of HRTX is $25.59 M
What is the all time high quarterly non current assets for Heron Therapeutics?
Heron Therapeutics all-time high quarterly long term assets is $51.28 M
What is Heron Therapeutics quarterly non current assets year-on-year change?
Over the past year, HRTX quarterly long term assets has changed by -$9.63 M (-27.34%)